Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-02-23 @ 4:29 PM
Study NCT ID:
NCT00982566
Status:
COMPLETED
Last Update Posted:
2017-11-21
First Post:
2009-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer
Sponsor:
AbbVie
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M11-069
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mack Mabry, MD, Medical Director
Old Organization:
Abbott
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |